Clinical Trial Update: A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread [Phase 2]

View source ↗

Summary

This update reports Phase 2 results from a trial of nivolumab alone or in combination therapy for metastatic colorectal cancer, with results posted on 2025-11-0…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Microsatellite Unstable Colorectal Cancer, Microsatellite Stable Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-11-06